ARPA-H Launches $62.7M Program to Build FDA-Authorized Agentic AI for Heart Failure Care
HealthcareLdr · x · 2026-09-13
- ARPA-H launched ADVOCATE, a $62.7M program to build patient-facing agentic clinical AI for cardiovascular care, focused on heart failure.
- The goal is an autonomous "digital member of the care team" that continuously monitors heart failure patients, provides some care between visits, and escalates issues to clinicians. Selected teams will build patient-facing AI, a supervisory agentic AI, and a scalable deployment plan.
- A key element is close collaboration with the FDA to establish a regulatory framework for a new class of autonomous clinical AI, with partners including Kaiser Permanente.
More from Safety
- METR brings in Redwood staff for independent investigation of Anthropic alignment incidents — Jsevillamol · 2026-09-13
- Dario Amodei's new essay calls to pace the frontier; Anthropic opens systems to third-party evaluators — EvanHub · 2026-09-13
- OpenAI's 'Defender's gap' chart aligns with Dario's push to widen the US-China AI lead — testingcatalog · 2026-09-13
- RedWood/METR evals staffed with ex-lab insiders, warns of a "revolving door" regulatory cartel — beffjezos · 2026-09-13
- Sam Altman backs Dario's frontier-pacing call, commits to independent evaluators with employee-like access — tawnniee · 2026-09-13
- Why self-invited AI evals won't work: PwC-style oversight and the China chip angle — xiaosun86 · 2026-09-13